(DURHAM, North Carolina)– Two batches of quinapril and hydrochlorothiazide tablets made by Aurobindo Pharma USA are being recalled because they contain unsafe levels of nitrosamines. 

Nitrosamines may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time,

The recall includes lot Nos. QE2021005-A and QE2021010-A of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 12.5mg in 90-count bottles from Aurobindo Pharma with an expiration date of January 2023.

Aurobindo said it hasn’t received any reports of adverse events related to the recall. 

Those who take this medication should talk with their doctor before stopping use, according to the FDA.

Consumers with medical questions about the recall can call the company at 1-866-850-2876, or email Aurobindo at pvg@aurobindousa.com. 

For questions about returns of the medications, call 1-888-504-2014.